Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maria-Christina Rimpa"'
Autor:
Nikos Pantazis, Evmorfia Pechlivanidou, Anastasia Antoniadou, Karolina Akinosoglou, Ioannis Kalomenidis, Garyfallia Poulakou, Haralampos Milionis, Periklis Panagopoulos, Markos Marangos, Ioannis Katsarolis, Pinelopi Kazakou, Vasiliki Dimakopoulou, Anna-Louiza Chaliasou, Vasiliki Rapti, Eirini Christaki, Angelos Liontos, Vasileios Petrakis, Georgios Schinas, Dimitrios Biros, Maria-Christina Rimpa, Giota Touloumi
Publikováno v:
Microorganisms, Vol 11, Iss 8, p 1998 (2023)
Remdesivir was the first antiviral approved for treating COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective observational study of hospitalized adults who received remdesivi
Externí odkaz:
https://doaj.org/article/4d7eb4bd99eb4872959707740bb6624a
Autor:
Nikos Pantazis, Evmorfia Pechlivanidou, Anastasia Antoniadou, Karolina Akinosoglou, Ioannis Kalomenidis, Garyfallia Poulakou, Haralampos Milionis, Periklis Panagopoulos, Ioannis Katsarolis, Pinelopi Kazakou, Vasiliki Dimakopoulou, Anna-Louiza Chaliasou, Vasiliki Rapti, Angelos Liontos, Vasileios Petrakis, Georgios Schinas, Dimitrios Biros, Maria-Christina Rimpa, Giota Touloumi
Background Remdesivir was the first antiviral approved for COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. Methods Retrospective observational study of hospitalized adults who received remdesivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a217f579f6595467d01a709f1474218e
https://doi.org/10.21203/rs.3.rs-2516706/v1
https://doi.org/10.21203/rs.3.rs-2516706/v1
